{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:53:42Z","timestamp":1795190022033,"version":"4.10.3"},"reference-count":296,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1038\/s41568-023-00556-8","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T12:02:50Z","timestamp":1681214570000},"page":"317-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["The neural addiction of cancer"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-5269","authenticated-orcid":false,"given":"Claire","family":"Magnon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3807-2985","authenticated-orcid":false,"given":"Hubert","family":"Hondermarck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"556_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2020.03.034","volume":"181","author":"M Monje","year":"2020","unstructured":"Monje, M. et al. Roadmap for the emerging field of cancer neuroscience. Cell 181, 219\u2013222 (2020).","journal-title":"Cell"},{"key":"556_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","volume":"31","author":"B Boilly","year":"2017","unstructured":"Boilly, B., Faulkner, S., Jobling, P. & Hondermarck, H. Nerve dependence: from regeneration to cancer. Cancer Cell 31, 342\u2013354 (2017).","journal-title":"Cancer Cell"},{"key":"556_CR3","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/cncr.20198","volume":"100","author":"SI Hajdu","year":"2004","unstructured":"Hajdu, S. I. Greco-Roman thought about cancer. Cancer 100, 2048\u20132051 (2004).","journal-title":"Cancer"},{"key":"556_CR4","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/ijc.29134","volume":"136","author":"GB Faguet","year":"2015","unstructured":"Faguet, G. B. A brief history of cancer: age-old milestones underlying our current knowledge database. Int. J. Cancer 136, 2022\u20132036 (2015).","journal-title":"Int. J. Cancer"},{"key":"556_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm.2328","volume":"17","author":"MJ Bissell","year":"2011","unstructured":"Bissell, M. J. & Hines, W. C. Why don\u2019t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 17, 320\u2013329 (2011).","journal-title":"Nat. Med."},{"key":"556_CR6","first-page":"98","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget, S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 8, 98\u2013101 (1989).","journal-title":"Cancer Metastasis Rev."},{"key":"556_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182\u20131186 (1971).","journal-title":"N. Engl. J. Med."},{"key":"556_CR8","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1002\/cncr.24396","volume":"115","author":"C Liebig","year":"2009","unstructured":"Liebig, C., Ayala, G., Wilks, J. A., Berger, D. H. & Albo, D. Perineural invasion in cancer: a review of the literature. Cancer 115, 3379\u20133391 (2009).","journal-title":"Cancer"},{"key":"556_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrc.2016.38","volume":"16","author":"M Amit","year":"2016","unstructured":"Amit, M., Na\u2019ara, S. & Gil, Z. Mechanisms of cancer dissemination along nerves. Nat. Rev. Cancer 16, 399\u2013408 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"556_CR10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1073\/pnas.40.10.1014","volume":"40","author":"S Cohen","year":"1954","unstructured":"Cohen, S., Levi-Montalcini, R. & Hamburger, V. A nerve growth-stimulating factor isolated from sarcomas 37 and 180. Proc. Natl Acad. Sci. USA 40, 1014\u20131018 (1954).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"556_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1158\/0008-5472.CAN-07-1183","volume":"68","author":"E Adriaenssens","year":"2008","unstructured":"Adriaenssens, E. et al. Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 68, 346\u2013351 (2008).","journal-title":"Cancer Res."},{"key":"556_CR12","first-page":"49","volume":"14","author":"R Levi-Montalcini","year":"1954","unstructured":"Levi-Montalcini, R., Meyer, H. & Hamburger, V. In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embryo. Cancer Res. 14, 49\u201357 (1954).","journal-title":"Cancer Res."},{"key":"556_CR13","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/jnci\/dji401","volume":"97","author":"AN Saul","year":"2005","unstructured":"Saul, A. N. et al. Chronic stress and susceptibility to skin cancer. J. Natl Cancer Inst. 97, 1760\u20131767 (2005).","journal-title":"J. Natl Cancer Inst."},{"key":"556_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S1470-2045(04)01597-9","volume":"5","author":"EM Reiche","year":"2004","unstructured":"Reiche, E. M., Nunes, S. O. & Morimoto, H. K. Stress, depression, the immune system, and cancer. Lancet Oncol. 5, 617\u2013625 (2004).","journal-title":"Lancet Oncol."},{"key":"556_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1126\/science.168638","volume":"189","author":"V Riley","year":"1975","unstructured":"Riley, V. Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 189, 465\u2013467 (1975).","journal-title":"Science"},{"key":"556_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1126\/science.7200261","volume":"216","author":"MA Visintainer","year":"1982","unstructured":"Visintainer, M. A., Volpicelli, J. R. & Seligman, M. E. Tumor rejection in rats after inescapable or escapable shock. Science 216, 437\u2013439 (1982).","journal-title":"Science"},{"key":"556_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.109924","volume":"205","author":"LS Sklar","year":"1979","unstructured":"Sklar, L. S. & Anisman, H. Stress and coping factors influence tumor growth. Science 205, 513\u2013515 (1979).","journal-title":"Science"},{"key":"556_CR18","doi-asserted-by":"publisher","first-page":"1236361","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon, C. et al. Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361 (2013).","journal-title":"Science"},{"key":"556_CR19","doi-asserted-by":"publisher","first-page":"250ra115","DOI":"10.1126\/scitranslmed.3009569","volume":"6","author":"CM Zhao","year":"2014","unstructured":"Zhao, C. M. et al. Denervation suppresses gastric tumorigenesis. Sci. Transl Med. 6, 250ra115 (2014).","journal-title":"Sci. Transl Med."},{"key":"556_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","volume":"31","author":"Y Hayakawa","year":"2017","unstructured":"Hayakawa, Y. et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer Cell 31, 21\u201334 (2017).","journal-title":"Cancer Cell"},{"key":"556_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.stem.2015.02.006","volume":"16","author":"SC Peterson","year":"2015","unstructured":"Peterson, S. C. et al. Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches. Cell Stem Cell 16, 400\u2013412 (2015).","journal-title":"Cell Stem Cell"},{"key":"556_CR22","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1158\/0008-5472.CAN-13-2050","volume":"74","author":"RE Stopczynski","year":"2014","unstructured":"Stopczynski, R. E. et al. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. Cancer Res. 74, 1718\u20131727 (2014).","journal-title":"Cancer Res."},{"key":"556_CR23","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1073\/pnas.1512603113","volume":"113","author":"JL Saloman","year":"2016","unstructured":"Saloman, J. L. et al. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer. Proc. Natl Acad. Sci. USA 113, 3078\u20133083 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"556_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ccell.2018.10.010","volume":"34","author":"BW Renz","year":"2018","unstructured":"Renz, B. W. et al. \u03b22 Adrenergic-neurotrophin feedforward loop promotes pancreatic cancer. Cancer Cell 34, 863\u2013867 (2018).","journal-title":"Cancer Cell"},{"key":"556_CR25","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2020.10.016","volume":"183","author":"RS Banh","year":"2020","unstructured":"Banh, R. S. et al. Neurons release serine to support mRNA translation in pancreatic cancer. Cell 183, 1202\u20131218 (2020).","journal-title":"Cell"},{"key":"556_CR26","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.molonc.2015.05.001","volume":"9","author":"J Pundavela","year":"2015","unstructured":"Pundavela, J. et al. Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer. Mol. Oncol. 9, 1626\u20131635 (2015).","journal-title":"Mol. Oncol."},{"key":"556_CR27","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41593-019-0430-3","volume":"22","author":"A Kamiya","year":"2019","unstructured":"Kamiya, A. et al. Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression. Nat. Neurosci. 22, 1289\u20131305 (2019).","journal-title":"Nat. Neurosci."},{"key":"556_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147276","author":"SM Gysler","year":"2021","unstructured":"Gysler, S. M. & Drapkin, R. Tumor innervation: peripheral nerves take control of the tumor microenvironment. J. Clin. Investig. https:\/\/doi.org\/10.1172\/JCI147276 (2021).","journal-title":"J. Clin. Investig."},{"key":"556_CR29","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1158\/0008-5472.CAN-20-2793","volume":"81","author":"DA Silverman","year":"2021","unstructured":"Silverman, D. A. et al. Cancer-associated neurogenesis and nerve-cancer cross-talk. Cancer Res. 81, 1431\u20131440 (2021).","journal-title":"Cancer Res."},{"key":"556_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","volume":"20","author":"AH Zahalka","year":"2020","unstructured":"Zahalka, A. H. & Frenette, P. S. Nerves in cancer. Nat. Rev. Cancer 20, 143\u2013157 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"556_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-3-030-73119-9_15","volume":"1329","author":"C Magnon","year":"2021","unstructured":"Magnon, C. The adrenergic nerve network in cancer. Adv. Exp. Med. Biol. 1329, 271\u2013294 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"556_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1749-6632.1998.tb09546.x","volume":"840","author":"BS McEwen","year":"1998","unstructured":"McEwen, B. S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. NY Acad. Sci. 840, 33\u201344 (1998).","journal-title":"Ann. NY Acad. Sci."},{"key":"556_CR33","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","volume":"567","author":"MMS Obradovic","year":"2019","unstructured":"Obradovic, M. M. S. et al. Glucocorticoids promote breast cancer metastasis. Nature 567, 540\u2013544 (2019).","journal-title":"Nature"},{"key":"556_CR34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cphy.c150015","volume":"6","author":"JP Herman","year":"2016","unstructured":"Herman, J. P. et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr. Physiol. 6, 603\u2013621 (2016).","journal-title":"Compr. Physiol."},{"key":"556_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fendo.2017.00101","volume":"8","author":"N Gallo-Payet","year":"2017","unstructured":"Gallo-Payet, N., Martinez, A. & Lacroix, A. Editorial: ACTH action in the adrenal cortex: from molecular biology to pathophysiology. Front. Endocrinol. 8, 101 (2017).","journal-title":"Front. Endocrinol."},{"key":"556_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM198008213030806","volume":"303","author":"PE Cryer","year":"1980","unstructured":"Cryer, P. E. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N. Engl. J. Med. 303, 436\u2013444 (1980).","journal-title":"N. Engl. J. Med."},{"key":"556_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker, P. H. et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12, 939\u2013944 (2006).","journal-title":"Nat. Med."},{"key":"556_CR38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1749-6632.1995.tb44676.x","volume":"771","author":"R Kvetnansky","year":"1995","unstructured":"Kvetnansky, R. et al. Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann. NY Acad. Sci. 771, 131\u2013158 (1995).","journal-title":"Ann. NY Acad. Sci."},{"key":"556_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1196\/annals.1410.053","volume":"1148","author":"M Ehrhart-Bornstein","year":"2008","unstructured":"Ehrhart-Bornstein, M. & Bornstein, S. R. Cross-talk between adrenal medulla and adrenal cortex in stress. Ann. NY Acad. Sci. 1148, 112\u2013117 (2008).","journal-title":"Ann. NY Acad. Sci."},{"key":"556_CR40","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1210\/jcem.86.12.8106","volume":"86","author":"N Zuckerman-Levin","year":"2001","unstructured":"Zuckerman-Levin, N., Tiosano, D., Eisenhofer, G., Bornstein, S. & Hochberg, Z. The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency. J. Clin. Endocrinol. Metab. 86, 5920\u20135924 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"556_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/cne.902740107","volume":"274","author":"ET Cunningham Jr","year":"1988","unstructured":"Cunningham, E. T. Jr & Sawchenko, P. E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 274, 60\u201376 (1988).","journal-title":"J. Comp. Neurol."},{"key":"556_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10571-017-0543-8","volume":"38","author":"JP Herman","year":"2018","unstructured":"Herman, J. P. Regulation of hypothalamo-pituitary-adrenocortical responses to stressors by the nucleus of the solitary tract\/dorsal vagal complex. Cell Mol. Neurobiol. 38, 25\u201335 (2018).","journal-title":"Cell Mol. Neurobiol."},{"key":"556_CR43","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/1097-0142(197704)39:4<1482::AID-CNCR2820390420>3.0.CO;2-P","volume":"39","author":"LJ Peters","year":"1977","unstructured":"Peters, L. J. & Kelly, H. The influence of stress and stress hormones on the transplantability of a non-immunogenic syngeneic murine tumor. Cancer 39, 1482\u20131488 (1977).","journal-title":"Cancer"},{"key":"556_CR44","first-page":"190","volume":"9","author":"T Sigurdsson","year":"2015","unstructured":"Sigurdsson, T. & Duvarci, S. Hippocampal-prefrontal interactions in cognition, behavior and psychiatric disease. Front. Syst. Neurosci. 9, 190 (2015).","journal-title":"Front. Syst. Neurosci."},{"key":"556_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejcsup.2014.03.003","volume":"12","author":"SB Schagen","year":"2014","unstructured":"Schagen, S. B. et al. Monitoring and optimising cognitive function in cancer patients: present knowledge and future directions. EJC Suppl. 12, 29\u201340 (2014).","journal-title":"EJC Suppl."},{"key":"556_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-clinpsy-050817-084903","volume":"14","author":"TA Ahles","year":"2018","unstructured":"Ahles, T. A. & Root, J. C. Cognitive effects of cancer and cancer treatments. Annu. Rev. Clin. Psychol. 14, 425\u2013451 (2018).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"556_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10549-007-9686-5","volume":"110","author":"TA Ahles","year":"2008","unstructured":"Ahles, T. A. et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res. Treat. 110, 143\u2013152 (2008).","journal-title":"Breast Cancer Res. Treat."},{"key":"556_CR48","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1200\/JCO.2015.63.0905","volume":"33","author":"JL Vardy","year":"2015","unstructured":"Vardy, J. L. et al. Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study. J. Clin. Oncol. 33, 4085\u20134092 (2015).","journal-title":"J. Clin. Oncol."},{"key":"556_CR49","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.2013.54.2050","volume":"32","author":"JS Mandelblatt","year":"2014","unstructured":"Mandelblatt, J. S. et al. Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J. Clin. Oncol. 32, 1909\u20131918 (2014).","journal-title":"J. Clin. Oncol."},{"key":"556_CR50","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.ejca.2014.05.026","volume":"50","author":"M Lange","year":"2014","unstructured":"Lange, M. et al. Baseline cognitive functions among elderly patients with localised breast cancer. Eur. J. Cancer 50, 2181\u20132189 (2014).","journal-title":"Eur. J. Cancer"},{"key":"556_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025349","volume":"6","author":"L Bergouignan","year":"2011","unstructured":"Bergouignan, L. et al. Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. PLoS ONE\u00a06, e25349 (2011).","journal-title":"PLoS ONE"},{"key":"556_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.concog.2015.04.016","volume":"35","author":"N Morel","year":"2015","unstructured":"Morel, N. et al. Emotional specificities of autobiographical memory after breast cancer diagnosis. Conscious. Cogn. 35, 42\u201352 (2015).","journal-title":"Conscious. Cogn."},{"key":"556_CR53","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.1523\/JNEUROSCI.1184-06.2006","volume":"26","author":"C Liston","year":"2006","unstructured":"Liston, C. et al. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J. Neurosci. 26, 7870\u20137874 (2006).","journal-title":"J. Neurosci."},{"key":"556_CR54","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1523\/JNEUROSCI.22-15-06810.2002","volume":"22","author":"A Vyas","year":"2002","unstructured":"Vyas, A., Mitra, R., Shankaranarayana Rao, B. S. & Chattarji, S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 22, 6810\u20136818 (2002).","journal-title":"J. Neurosci."},{"key":"556_CR55","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1460-9568.2006.05024.x","volume":"24","author":"MS Murmu","year":"2006","unstructured":"Murmu, M. S. et al. Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. Eur. J. Neurosci. 24, 1477\u20131487 (2006).","journal-title":"Eur. J. Neurosci."},{"key":"556_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0306-4522(95)00259-L","volume":"69","author":"AM Magarinos","year":"1995","unstructured":"Magarinos, A. M. & McEwen, B. S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69, 89\u201398 (1995).","journal-title":"Neuroscience"},{"key":"556_CR57","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1523\/JNEUROSCI.17-07-02492.1997","volume":"17","author":"E Gould","year":"1997","unstructured":"Gould, E., McEwen, B. S., Tanapat, P., Galea, L. A. & Fuchs, E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J. Neurosci. 17, 2492\u20132498 (1997).","journal-title":"J. Neurosci."},{"key":"556_CR58","doi-asserted-by":"publisher","first-page":"9371","DOI":"10.1073\/pnas.0504011102","volume":"102","author":"R Mitra","year":"2005","unstructured":"Mitra, R., Jadhav, S., McEwen, B. S., Vyas, A. & Chattarji, S. Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. Proc. Natl Acad. Sci. USA 102, 9371\u20139376 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"556_CR59","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1523\/JNEUROSCI.1598-05.2005","volume":"25","author":"JJ Cerqueira","year":"2005","unstructured":"Cerqueira, J. J. et al. Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J. Neurosci. 25, 7792\u20137800 (2005).","journal-title":"J. Neurosci."},{"key":"556_CR60","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1073\/pnas.0807041106","volume":"106","author":"C Liston","year":"2009","unstructured":"Liston, C., McEwen, B. S. & Casey, B. J. Psychosocial stress reversibly disrupts prefrontal processing and attentional control. Proc. Natl Acad. Sci. USA 106, 912\u2013917 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"556_CR61","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0896-6273(03)00757-8","volume":"40","author":"B Moghaddam","year":"2003","unstructured":"Moghaddam, B. Bringing order to the glutamate chaos in schizophrenia. Neuron 40, 881\u2013884 (2003).","journal-title":"Neuron"},{"key":"556_CR62","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3389\/fpsyt.2018.00767","volume":"9","author":"CT Li","year":"2018","unstructured":"Li, C. T., Yang, K. C. & Lin, W. C. Glutamatergic dysfunction and glutamatergic compounds for major psychiatric disorders: evidence from clinical neuroimaging studies. Front. Psychiatry 9, 767 (2018).","journal-title":"Front. Psychiatry"},{"key":"556_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2020.100015","author":"KE Schoonover","year":"2020","unstructured":"Schoonover, K. E., Dienel, S. J. & Lewis, D. A. Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: insights for rational biomarker development. Biomark. Neuropsychiatry https:\/\/doi.org\/10.1016\/j.bionps.2020.100015 (2020).","journal-title":"Biomark. Neuropsychiatry"},{"key":"556_CR64","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrn2639","volume":"10","author":"SJ Lupien","year":"2009","unstructured":"Lupien, S. J., McEwen, B. S., Gunnar, M. R. & Heim, C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 10, 434\u2013445 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"556_CR65","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","volume":"573","author":"HS Venkatesh","year":"2019","unstructured":"Venkatesh, H. S. et al. Electrical and synaptic integration of glioma into neural circuits. Nature 573, 539\u2013545 (2019).","journal-title":"Nature"},{"key":"556_CR66","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","volume":"573","author":"V Venkataramani","year":"2019","unstructured":"Venkataramani, V. et al. Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature 573, 532\u2013538 (2019).","journal-title":"Nature"},{"key":"556_CR67","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","volume":"573","author":"Q Zeng","year":"2019","unstructured":"Zeng, Q. et al. Synaptic proximity enables NMDAR signalling to promote brain metastasis. Nature 573, 526\u2013531 (2019).","journal-title":"Nature"},{"key":"556_CR68","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.1073\/pnas.091113598","volume":"98","author":"W Rzeski","year":"2001","unstructured":"Rzeski, W., Turski, L. & Ikonomidou, C. Glutamate antagonists limit tumor growth. Proc. Natl Acad. Sci. USA 98, 6372\u20136377 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"556_CR69","doi-asserted-by":"publisher","first-page":"109475","DOI":"10.1016\/j.celrep.2021.109475","volume":"36","author":"V Martirosian","year":"2021","unstructured":"Martirosian, V. et al. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination. Cell Rep. 36, 109475 (2021).","journal-title":"Cell Rep."},{"key":"556_CR70","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s43018-021-00254-0","volume":"2","author":"F Klemm","year":"2021","unstructured":"Klemm, F. et al. Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis. Nat. Cancer 2, 1086\u20131101 (2021).","journal-title":"Nat. Cancer"},{"key":"556_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008566","volume":"5","author":"L Musazzi","year":"2010","unstructured":"Musazzi, L. et al. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal\/frontal cortex: the dampening action of antidepressants. PLoS ONE\u00a05, e8566 (2010).","journal-title":"PLoS ONE"},{"key":"556_CR72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn3138","volume":"13","author":"M Popoli","year":"2011","unstructured":"Popoli, M., Yan, Z., McEwen, B. S. & Sanacora, G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat. Rev. Neurosci. 13, 22\u201337 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"556_CR73","doi-asserted-by":"publisher","first-page":"127ra136","DOI":"10.1126\/scitranslmed.3003016","volume":"4","author":"JM Munson","year":"2012","unstructured":"Munson, J. M. et al. Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma. Sci. Transl Med. 4, 127ra136 (2012).","journal-title":"Sci. Transl Med."},{"key":"556_CR74","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1158\/1078-0432.CCR-15-2535","volume":"22","author":"S Rajamanickam","year":"2016","unstructured":"Rajamanickam, S. et al. Inhibition of FoxM1-mediated DNA repair by imipramine blue suppresses breast cancer growth and metastasis. Clin. Cancer Res. 22, 3524\u20133536 (2016).","journal-title":"Clin. Cancer Res."},{"key":"556_CR75","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/35081582","volume":"2","author":"RM Buijs","year":"2001","unstructured":"Buijs, R. M. & Kalsbeek, A. Hypothalamic integration of central and peripheral clocks. Nat. Rev. Neurosci. 2, 521\u2013526 (2001).","journal-title":"Nat. Rev. Neurosci."},{"key":"556_CR76","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0006-8993(72)90054-6","volume":"42","author":"RY Moore","year":"1972","unstructured":"Moore, R. Y. & Eichler, V. B. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res. 42, 201\u2013206 (1972).","journal-title":"Brain Res."},{"key":"556_CR77","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1073\/pnas.69.6.1583","volume":"69","author":"FK Stephan","year":"1972","unstructured":"Stephan, F. K. & Zucker, I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc. Natl Acad. Sci. USA 69, 1583\u20131586 (1972).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"556_CR78","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1158\/0008-5472.CAN-19-0566","volume":"79","author":"AA Shafi","year":"2019","unstructured":"Shafi, A. A. & Knudsen, K. E. Cancer and the circadian clock. Cancer Res. 79, 3806\u20133814 (2019).","journal-title":"Cancer Res."},{"key":"556_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000228","volume":"17","author":"Y Lee","year":"2019","unstructured":"Lee, Y. et al. G1\/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment. PLoS Biol. 17, e3000228 (2019).","journal-title":"PLoS Biol."},{"key":"556_CR80","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4327","volume":"6","author":"J Shilts","year":"2018","unstructured":"Shilts, J., Chen, G. & Hughey, J. J. Evidence for widespread dysregulation of circadian clock progression in human cancer. PeerJ 6, e4327 (2018).","journal-title":"PeerJ"},{"key":"556_CR81","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cmet.2016.07.001","volume":"24","author":"T Papagiannakopoulos","year":"2016","unstructured":"Papagiannakopoulos, T. et al. Circadian rhythm disruption promotes lung tumorigenesis. Cell Metab. 24, 324\u2013331 (2016).","journal-title":"Cell Metab."},{"key":"556_CR82","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.cub.2015.06.012","volume":"25","author":"KC Van Dycke","year":"2015","unstructured":"Van Dycke, K. C. et al. Chronically alternating light cycles increase breast cancer risk in mice. Curr. Biol. 25, 1932\u20131937 (2015).","journal-title":"Curr. Biol."},{"key":"556_CR83","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/jnci\/93.20.1557","volume":"93","author":"S Davis","year":"2001","unstructured":"Davis, S., Mirick, D. K. & Stevens, R. G. Night shift work, light at night, and risk of breast cancer. J. Natl Cancer Inst. 93, 1557\u20131562 (2001).","journal-title":"J. Natl Cancer Inst."},{"key":"556_CR84","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.4161\/15384101.2014.954454","volume":"13","author":"C Cadenas","year":"2014","unstructured":"Cadenas, C. et al. Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle 13, 3282\u20133291 (2014).","journal-title":"Cell Cycle"},{"key":"556_CR85","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.ede.0000152525.21924.54","volume":"16","author":"RG Stevens","year":"2005","unstructured":"Stevens, R. G. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 16, 254\u2013258 (2005).","journal-title":"Epidemiology"},{"key":"556_CR86","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/01.ede.0000249519.33978.31","volume":"18","author":"M Conlon","year":"2007","unstructured":"Conlon, M., Lightfoot, N. & Kreiger, N. Rotating shift work and risk of prostate cancer. Epidemiology 18, 182\u2013183 (2007).","journal-title":"Epidemiology"},{"key":"556_CR87","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1158\/1055-9965.EPI-16-1030","volume":"26","author":"MG Wendeu-Foyet","year":"2017","unstructured":"Wendeu-Foyet, M. G. & Menegaux, F. Circadian disruption and prostate cancer risk: an updated review of epidemiological evidences. Cancer Epidemiol. Biomark. Prev. 26, 985\u2013991 (2017).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"556_CR88","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1002\/ijc.31655","volume":"143","author":"K Papantoniou","year":"2018","unstructured":"Papantoniou, K. et al. Rotating night shift work and colorectal cancer risk in the nurses\u2019 health studies. Int. J. Cancer 143, 2709\u20132717 (2018).","journal-title":"Int. J. Cancer"},{"key":"556_CR89","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1152506","volume":"320","author":"JS O\u2019Neill","year":"2008","unstructured":"O\u2019Neill, J. S., Maywood, E. S., Chesham, J. E., Takahashi, J. S. & Hastings, M. H. cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 320, 949\u2013953 (2008).","journal-title":"Science"},{"key":"556_CR90","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/15973","volume":"2","author":"T Ueyama","year":"1999","unstructured":"Ueyama, T. et al. Suprachiasmatic nucleus: a central autonomic clock. Nat. Neurosci. 2, 1051\u20131053 (1999).","journal-title":"Nat. Neurosci."},{"key":"556_CR91","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/1096-9861(20010319)431:4<405::AID-CNE1079>3.0.CO;2-D","volume":"431","author":"RM Buijs","year":"2001","unstructured":"Buijs, R. M., Chun, S. J., Niijima, A., Romijn, H. J. & Nagai, K. Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. J. Comp. Neurol. 431, 405\u2013423 (2001).","journal-title":"J. Comp. Neurol."},{"key":"556_CR92","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(02)00961-3","volume":"111","author":"L Fu","year":"2002","unstructured":"Fu, L., Pelicano, H., Liu, J., Huang, P. & Lee, C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111, 41\u201350 (2002).","journal-title":"Cell"},{"key":"556_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010995","volume":"5","author":"S Lee","year":"2010","unstructured":"Lee, S., Donehower, L. A., Herron, A. J., Moore, D. D. & Fu, L. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS ONE 5, e10995 (2010).","journal-title":"PLoS ONE"},{"key":"556_CR94","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/cne.901800302","volume":"180","author":"RY Moore","year":"1978","unstructured":"Moore, R. Y., Halaris, A. E. & Jones, B. E. Serotonin neurons of the midbrain raphe: ascending projections. J. Comp. Neurol. 180, 417\u2013438 (1978).","journal-title":"J. Comp. Neurol."},{"key":"556_CR95","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0006-8993(00)02294-0","volume":"866","author":"ZG Jiang","year":"2000","unstructured":"Jiang, Z. G., Teshima, K., Yang, Y., Yoshioka, T. & Allen, C. N. Pre- and postsynaptic actions of serotonin on rat suprachiasmatic nucleus neurons. Brain Res. 866, 247\u2013256 (2000).","journal-title":"Brain Res."},{"key":"556_CR96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/074873049300800102","volume":"8","author":"DM Edgar","year":"1993","unstructured":"Edgar, D. M., Miller, J. D., Prosser, R. A., Dean, R. R. & Dement, W. C. Serotonin and the mammalian circadian system: II. Phase-shifting rat behavioral rhythms with serotonergic agonists. J. Biol. Rhythm. 8, 17\u201331 (1993).","journal-title":"J. Biol. Rhythm."},{"key":"556_CR97","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1097\/00001756-199507100-00014","volume":"6","author":"MA Rea","year":"1995","unstructured":"Rea, M. A., Barrera, J., Glass, J. D. & Gannon, R. L. Serotonergic potentiation of photic phase shifts of the circadian activity rhythm. Neuroreport 6, 1417\u20131420 (1995).","journal-title":"Neuroreport"},{"key":"556_CR98","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0306-4522(98)00635-6","volume":"91","author":"A Kalsbeek","year":"1999","unstructured":"Kalsbeek, A., Cutrera, R. A., Van Heerikhuize, J. J., Van Der Vliet, J. & Buijs, R. M. GABA release from suprachiasmatic nucleus terminals is necessary for the light-induced inhibition of nocturnal melatonin release in the rat. Neuroscience 91, 453\u2013461 (1999).","journal-title":"Neuroscience"},{"key":"556_CR99","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1046\/j.1460-9568.2000.00202.x","volume":"12","author":"A Kalsbeek","year":"2000","unstructured":"Kalsbeek, A. et al. Melatonin sees the light: blocking GABA-ergic transmission in the paraventricular nucleus induces daytime secretion of melatonin. Eur. J. Neurosci. 12, 3146\u20133154 (2000).","journal-title":"Eur. J. Neurosci."},{"key":"556_CR100","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/sj.eye.6702597","volume":"21","author":"R Brennan","year":"2007","unstructured":"Brennan, R., Jan, J. E. & Lyons, C. J. Light, dark, and melatonin: emerging evidence for the importance of melatonin in ocular physiology. Eye 21, 901\u2013908 (2007).","journal-title":"Eye"},{"key":"556_CR101","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/(SICI)1096-9861(19990405)406:2<171::AID-CNE3>3.0.CO;2-U","volume":"406","author":"R Teclemariam-Mesbah","year":"1999","unstructured":"Teclemariam-Mesbah, R., Ter Horst, G. J., Postema, F., Wortel, J. & Buijs, R. M. Anatomical demonstration of the suprachiasmatic nucleus-pineal pathway. J. Comp. Neurol. 406, 171\u2013182 (1999).","journal-title":"J. Comp. Neurol."},{"key":"556_CR102","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.3390\/ijms14048638","volume":"14","author":"A Carrillo-Vico","year":"2013","unstructured":"Carrillo-Vico, A., Lardone, P. J., Alvarez-Sanchez, N., Rodriguez-Rodriguez, A. & Guerrero, J. M. Melatonin: buffering the immune system. Int. J. Mol. Sci. 14, 8638\u20138683 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"556_CR103","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/jpi.12075","volume":"55","author":"JR Calvo","year":"2013","unstructured":"Calvo, J. R., Gonz\u00e1lez-Yanes, C. & Maldonado, M. D. The role of melatonin in the cells of the innate immunity: a review. J. Pineal Res. 55, 103\u2013120 (2013).","journal-title":"J. Pineal Res."},{"key":"556_CR104","first-page":"17","volume":"23","author":"G Glickman","year":"2002","unstructured":"Glickman, G., Levin, R. & Brainard, G. C. Ocular input for human melatonin regulation: relevance to breast cancer. Neuro Endocrinol. Lett. 23, 17\u201322 (2002).","journal-title":"Neuro Endocrinol. Lett."},{"key":"556_CR105","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/1097-0142(19860215)57:4<837::AID-CNCR2820570425>3.0.CO;2-O","volume":"57","author":"P Lissoni","year":"1986","unstructured":"Lissoni, P. et al. A clinical study of the pineal gland activity in oncologic patients. Cancer 57, 837\u2013842 (1986).","journal-title":"Cancer"},{"key":"556_CR106","doi-asserted-by":"publisher","first-page":"11174","DOI":"10.1158\/0008-5472.CAN-05-1945","volume":"65","author":"DE Blask","year":"2005","unstructured":"Blask, D. E. et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 65, 11174\u201311184 (2005).","journal-title":"Cancer Res."},{"key":"556_CR107","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1470-2045(07)70373-X","volume":"8","author":"K Straif","year":"2007","unstructured":"Straif, K. et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 8, 1065\u20131066 (2007).","journal-title":"Lancet Oncol."},{"key":"556_CR108","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S1470-2045(19)30455-3","volume":"20","author":"IARC Monographs Vol 124 Group.","year":"2019","unstructured":"IARC Monographs Vol 124 Group. Carcinogenicity of night shift work. Lancet Oncol. 20, 1058\u20131059 (2019).","journal-title":"Lancet Oncol."},{"key":"556_CR109","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1385\/ENDO:27:2:179","volume":"27","author":"DE Blask","year":"2005","unstructured":"Blask, D. E., Dauchy, R. T. & Sauer, L. A. Putting cancer to sleep at night: the neuroendocrine\/circadian melatonin signal. Endocrine 27, 179\u2013188 (2005).","journal-title":"Endocrine"},{"key":"556_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1556-7","volume":"10","author":"A Tarocco","year":"2019","unstructured":"Tarocco, A. et al. Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care. Cell Death Dis. 10, 317 (2019).","journal-title":"Cell Death Dis."},{"key":"556_CR111","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/jpi.12298","volume":"60","author":"L Mao","year":"2016","unstructured":"Mao, L. et al. Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma. J. Pineal Res. 60, 167\u2013177 (2016).","journal-title":"J. Pineal Res."},{"key":"556_CR112","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/jpi.12239","volume":"59","author":"S Xiang","year":"2015","unstructured":"Xiang, S. et al. Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal. J. Pineal Res. 59, 60\u201369 (2015).","journal-title":"J. Pineal Res."},{"key":"556_CR113","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-8993(91)90177-W","volume":"554","author":"CS Colwell","year":"1991","unstructured":"Colwell, C. S., Foster, R. G. & Menaker, M. NMDA receptor antagonists block the effects of light on circadian behavior in the mouse. Brain Res. 554, 105\u2013110 (1991).","journal-title":"Brain Res."},{"key":"556_CR114","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1126\/science.7527589","volume":"266","author":"JM Ding","year":"1994","unstructured":"Ding, J. M. et al. Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 266, 1713\u20131717 (1994).","journal-title":"Science"},{"key":"556_CR115","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0361-9230(92)90269-4","volume":"28","author":"H Abe","year":"1992","unstructured":"Abe, H., Rusak, B. & Robertson, H. A. NMDA and non-NMDA receptor antagonists inhibit photic induction of Fos protein in the hamster suprachiasmatic nucleus. Brain Res. Bull. 28, 831\u2013835 (1992).","journal-title":"Brain Res. Bull."},{"key":"556_CR116","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/074873049200700204","volume":"7","author":"CS Colwell","year":"1992","unstructured":"Colwell, C. S. & Menaker, M. NMDA as well as non-NMDA receptor antagonists can prevent the phase-shifting effects of light on the circadian system of the golden hamster. J. Biol. Rhythm. 7, 125\u2013136 (1992).","journal-title":"J. Biol. Rhythm."},{"key":"556_CR117","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1523\/JNEUROSCI.14-06-03635.1994","volume":"14","author":"MA Rea","year":"1994","unstructured":"Rea, M. A., Glass, J. D. & Colwell, C. S. Serotonin modulates photic responses in the hamster suprachiasmatic nuclei. J. Neurosci. 14, 3635\u20133642 (1994).","journal-title":"J. Neurosci."},{"key":"556_CR118","doi-asserted-by":"publisher","first-page":"34889","DOI":"10.18632\/oncotarget.26175","volume":"9","author":"E-H Dakir","year":"2018","unstructured":"Dakir, E.-H. et al. The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. Oncotarget 9, 34889\u201334910 (2018).","journal-title":"Oncotarget"},{"key":"556_CR119","doi-asserted-by":"publisher","first-page":"17593","DOI":"10.18632\/oncotarget.4307","volume":"8","author":"JJ Chen","year":"2017","unstructured":"Chen, J. J. et al. The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma. Oncotarget 8, 17593\u201317609 (2017).","journal-title":"Oncotarget"},{"key":"556_CR120","first-page":"1101","volume":"42","author":"JJ Chen","year":"2019","unstructured":"Chen, J. J., Zhang, L. N., Cai, N., Zhang, Z. & Ji, K. Antipsychotic agent pimozide promotes reversible proliferative suppression by inducing cellular quiescence in liver cancer. Oncol. Rep. 42, 1101\u20131109 (2019).","journal-title":"Oncol. Rep."},{"key":"556_CR121","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3892\/ijo.2015.3229","volume":"48","author":"W Zhou","year":"2016","unstructured":"Zhou, W. et al. The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation. Int. J. Oncol. 48, 322\u2013328 (2016).","journal-title":"Int. J. Oncol."},{"key":"556_CR122","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1634\/theoncologist.2011-0031","volume":"16","author":"TA Mohammed","year":"2011","unstructured":"Mohammed, T. A. et al. A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. Oncologist 16, 835\u2013843 (2011).","journal-title":"Oncologist"},{"key":"556_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2957-y","volume":"16","author":"F Caponigro","year":"2016","unstructured":"Caponigro, F. et al. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and\/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial. BMC Cancer 16, 918 (2016).","journal-title":"BMC Cancer"},{"key":"556_CR124","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.mayocp.2012.02.012","volume":"87","author":"CH Kao","year":"2012","unstructured":"Kao, C. H. et al. Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study. Mayo Clin. Proc. 87, 430\u2013436 (2012).","journal-title":"Mayo Clin. Proc."},{"key":"556_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7266","volume":"6","author":"P Bonnavion","year":"2015","unstructured":"Bonnavion, P., Jackson, A. C., Carter, M. E. & de Lecea, L. Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses. Nat. Commun. 6, 6266 (2015).","journal-title":"Nat. Commun."},{"key":"556_CR126","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fnins.2020.00101","volume":"14","author":"M Fakhoury","year":"2020","unstructured":"Fakhoury, M., Salman, I., Najjar, W., Merhej, G. & Lawand, N. The lateral hypothalamus: an uncharted territory for processing peripheral neurogenic inflammation. Front. Neurosci. 14, 101 (2020).","journal-title":"Front. Neurosci."},{"key":"556_CR127","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L de Lecea","year":"1998","unstructured":"de Lecea, L. et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. USA 95, 322\u2013327 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"556_CR128","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573\u2013585 (1998).","journal-title":"Cell"},{"key":"556_CR129","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-019-0948-2","volume":"566","author":"CS McAlpine","year":"2019","unstructured":"McAlpine, C. S. et al. Sleep modulates haematopoiesis and protects against atherosclerosis. Nature 566, 383\u2013387 (2019).","journal-title":"Nature"},{"key":"556_CR130","doi-asserted-by":"publisher","first-page":"9595","DOI":"10.1158\/0008-5472.CAN-05-2138","volume":"65","author":"PK Verkasalo","year":"2005","unstructured":"Verkasalo, P. K. et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 65, 9595\u20139600 (2005).","journal-title":"Cancer Res."},{"key":"556_CR131","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1365-2869.2008.00732.x","volume":"18","author":"L Gallicchio","year":"2009","unstructured":"Gallicchio, L. & Kalesan, B. Sleep duration and mortality: a systematic review and meta-analysis. J. Sleep Res. 18, 148\u2013158 (2009).","journal-title":"J. Sleep Res."},{"key":"556_CR132","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/sj.bjc.6604684","volume":"99","author":"M Kakizaki","year":"2008","unstructured":"Kakizaki, M. et al. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br. J. Cancer 99, 1502\u20131505 (2008).","journal-title":"Br. J. Cancer"},{"key":"556_CR133","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/cncr.25507","volume":"117","author":"CL Thompson","year":"2011","unstructured":"Thompson, C. L. et al. Short duration of sleep increases risk of colorectal adenoma. Cancer 117, 841\u2013847 (2011).","journal-title":"Cancer"},{"key":"556_CR134","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1158\/0008-5472.CAN-13-3014","volume":"74","author":"F Hakim","year":"2014","unstructured":"Hakim, F. et al. Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling. Cancer Res. 74, 1329\u20131337 (2014).","journal-title":"Cancer Res."},{"key":"556_CR135","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cmet.2018.04.021","volume":"28","author":"JC Borniger","year":"2018","unstructured":"Borniger, J. C. et al. A Role for hypocretin\/orexin in metabolic and sleep abnormalities in a mouse model of non-metastatic breast cancer. Cell Metab. 28, 118\u2013129.e5 (2018).","journal-title":"Cell Metab."},{"key":"556_CR136","first-page":"264","volume":"39","author":"T Bennett","year":"2014","unstructured":"Bennett, T., Bray, D. & Neville, M. W. Suvorexant, a dual orexin receptor antagonist for the management of insomnia. P T 39, 264\u2013266 (2014).","journal-title":"P T"},{"key":"556_CR137","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.18632\/oncotarget.24084","volume":"9","author":"S Dayot","year":"2018","unstructured":"Dayot, S. et al. In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1\/orexin-A and almorexant in pancreatic ductal adenocarcinoma. Oncotarget 9, 6952\u20136967 (2018).","journal-title":"Oncotarget"},{"key":"556_CR138","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1126\/science.6250220","volume":"209","author":"RH Simon","year":"1980","unstructured":"Simon, R. H., Lovett, E. J. III, Tomaszek, D. & Lundy, J. Electrical stimulation of the midbrain mediates metastatic tumor growth. Science 209, 1132\u20131133 (1980).","journal-title":"Science"},{"key":"556_CR139","first-page":"254","volume":"82","author":"J Lundy","year":"1977","unstructured":"Lundy, J., Lovett, E. J. III & Conran, P. Pulmonary metastases, a potential biologic consequence of anesthetic-induced immunosuppression by thiopental. Surgery 82, 254\u2013256 (1977).","journal-title":"Surgery"},{"key":"556_CR140","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/jnci\/51.4.1349","volume":"51","author":"C Peraino","year":"1973","unstructured":"Peraino, C., Fry, R. J. & Staffeldt, E. Brief communication: enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital. J. Natl Cancer Inst. 51, 1349\u20131350 (1973).","journal-title":"J. Natl Cancer Inst."},{"key":"556_CR141","first-page":"3623","volume":"37","author":"C Peraino","year":"1977","unstructured":"Peraino, C., Fry, R. J. & Staffeldt, E. Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res. 37, 3623\u20133627 (1977).","journal-title":"Cancer Res."},{"key":"556_CR142","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrn.2016.165","volume":"18","author":"M Morales","year":"2017","unstructured":"Morales, M. & Margolis, E. B. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat. Rev. Neurosci. 18, 73\u201385 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"556_CR143","doi-asserted-by":"publisher","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","volume":"1","author":"RS Kahn","year":"2015","unstructured":"Kahn, R. S. et al. Schizophrenia. Nat. Rev. Dis. Prim. 1, 15067 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"556_CR144","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1470-2045(10)70085-1","volume":"11","author":"LM Howard","year":"2010","unstructured":"Howard, L. M. et al. Cancer diagnosis in people with severe mental illness: practical and ethical issues. Lancet Oncol. 11, 797\u2013804 (2010).","journal-title":"Lancet Oncol."},{"key":"556_CR145","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S2215-0366(19)30414-6","volume":"7","author":"M Solmi","year":"2020","unstructured":"Solmi, M. et al. Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people. Lancet Psychiatry 7, 52\u201363 (2020).","journal-title":"Lancet Psychiatry"},{"key":"556_CR146","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1096\/fj.02-0145fje","volume":"16","author":"MA Teunis","year":"2002","unstructured":"Teunis, M. A. et al. Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system. FASEB J. 16, 1465\u20131467 (2002).","journal-title":"FASEB J."},{"key":"556_CR147","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.drup.2014.09.001","volume":"17","author":"MA Peters","year":"2014","unstructured":"Peters, M. A. et al. Dopamine and serotonin regulate tumor behavior by affecting angiogenesis. Drug Resist. Updat. 17, 96\u2013104 (2014).","journal-title":"Drug Resist. Updat."},{"key":"556_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05283-5","volume":"9","author":"TL Ben-Shaanan","year":"2018","unstructured":"Ben-Shaanan, T. L. et al. Modulation of anti-tumor immunity by the brain\u2019s reward system. Nat. Commun. 9, 2723 (2018).","journal-title":"Nat. Commun."},{"key":"556_CR149","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-019-1219-y","volume":"569","author":"P Mauffrey","year":"2019","unstructured":"Mauffrey, P. et al. Progenitors from the central nervous system drive neurogenesis in cancer. Nature 569, 672\u2013678 (2019).","journal-title":"Nature"},{"key":"556_CR150","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1126\/science.abc6108","volume":"374","author":"S Carloni","year":"2021","unstructured":"Carloni, S. et al. Identification of a choroid plexus vascular barrier closing during intestinal inflammation. Science 374, 439\u2013448 (2021).","journal-title":"Science"},{"key":"556_CR151","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bbi.2010.10.012","volume":"25","author":"SK Lutgendorf","year":"2011","unstructured":"Lutgendorf, S. K. et al. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav. Immun. 25, 250\u2013255 (2011).","journal-title":"Brain Behav. Immun."},{"key":"556_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001363","volume":"10","author":"JP Campbell","year":"2012","unstructured":"Campbell, J. P. et al. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol. 10, e1001363 (2012).","journal-title":"PLoS Biol."},{"key":"556_CR153","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan, E. K. et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 70, 7042\u20137052 (2010).","journal-title":"Cancer Res."},{"key":"556_CR154","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbi.2016.06.011","volume":"57","author":"A Chang","year":"2016","unstructured":"Chang, A. et al. \u03b22-Adrenoceptors on tumor cells play a critical role in stress-enhanced metastasis in a mouse model of breast cancer. Brain Behav. Immun. 57, 106\u2013115 (2016).","journal-title":"Brain Behav. Immun."},{"key":"556_CR155","first-page":"874","volume":"123","author":"S Hassan","year":"2013","unstructured":"Hassan, S. et al. Behavioral stress accelerates prostate cancer development in mice. J. Clin. Investig. 123, 874\u2013886 (2013).","journal-title":"J. Clin. Investig."},{"key":"556_CR156","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10549-011-1348-y","volume":"130","author":"KS Madden","year":"2011","unstructured":"Madden, K. S., Szpunar, M. J. & Brown, E. B.\u03b2-Adrenergic receptors (\u03b2-AR) regulate VEGF and IL-6 production by divergent pathways in high \u03b2-AR-expressing breast cancer cell lines. Breast Cancer Res. Treat. 130, 747\u2013758 (2011).","journal-title":"Breast Cancer Res. Treat."},{"key":"556_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7426","volume":"6","author":"JW Eng","year":"2015","unstructured":"Eng, J. W. et al. Housing temperature-induced stress drives therapeutic resistance in murine tumour models through \u03b22-adrenergic receptor activation. Nat. Commun. 6, 6426 (2015).","journal-title":"Nat. Commun."},{"key":"556_CR158","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbi.2014.02.019","volume":"40","author":"C Kim-Fuchs","year":"2014","unstructured":"Kim-Fuchs, C. et al. Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav. Immun. 40, 40\u201347 (2014).","journal-title":"Brain Behav. Immun."},{"key":"556_CR159","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1038\/bjc.2013.205","volume":"108","author":"E Pasquier","year":"2013","unstructured":"Pasquier, E. et al. \u03b2-Blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. Br. J. Cancer 108, 2485\u20132494 (2013).","journal-title":"Br. J. Cancer"},{"key":"556_CR160","doi-asserted-by":"publisher","first-page":"161","DOI":"10.18632\/oncotarget.1083","volume":"5","author":"JK Wolter","year":"2014","unstructured":"Wolter, J. K. et al. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma. Oncotarget 5, 161\u2013172 (2014).","journal-title":"Oncotarget"},{"key":"556_CR161","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1349-7006.2002.tb01313.x","volume":"93","author":"H Hasegawa","year":"2002","unstructured":"Hasegawa, H. & Saiki, I. Psychosocial stress augments tumor development through \u03b2-adrenergic activation in mice. Jpn. J. Cancer Res. 93, 729\u2013735 (2002).","journal-title":"Jpn. J. Cancer Res."},{"key":"556_CR162","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/SLA.0b013e318211d7b5","volume":"253","author":"Y Goldfarb","year":"2011","unstructured":"Goldfarb, Y. et al. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann. Surg. 253, 798\u2013810 (2011).","journal-title":"Ann. Surg."},{"key":"556_CR163","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1158\/1078-0432.CCR-10-1890","volume":"17","author":"E Vanhecke","year":"2011","unstructured":"Vanhecke, E. et al. Brain-derived neurotrophic factor and neurotrophin-4\/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin. Cancer Res. 17, 1741\u20131752 (2011).","journal-title":"Clin. Cancer Res."},{"key":"556_CR164","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/ijc.29046","volume":"136","author":"K Dobrenis","year":"2015","unstructured":"Dobrenis, K., Gauthier, L. R., Barroca, V. & Magnon, C. Granulocyte colony-stimulating factor off-target effect on nerve outgrowth promotes prostate cancer development. Int. J. Cancer 136, 982\u2013988 (2015).","journal-title":"Int. J. Cancer"},{"key":"556_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02108-6","author":"CC Jiang","year":"2021","unstructured":"Jiang, C. C. et al. Tumor innervation is triggered by endoplasmic reticulum stress. Oncogene https:\/\/doi.org\/10.1038\/s41388-021-02108-6 (2021).","journal-title":"Oncogene"},{"key":"556_CR166","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1126\/science.1241776","volume":"341","author":"JT Isaacs","year":"2013","unstructured":"Isaacs, J. T. Cancer. Prostate cancer takes nerve. Science 341, 134\u2013135 (2013).","journal-title":"Science"},{"key":"556_CR167","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1158\/0008-5472.CAN-16-1701","volume":"78","author":"JK Allen","year":"2018","unstructured":"Allen, J. K. et al. Sustained adrenergic signaling promotes intratumoral innervation through BDNF induction. Cancer Res. 78, 3233\u20133242 (2018).","journal-title":"Cancer Res."},{"key":"556_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06640-0","volume":"9","author":"M Madeo","year":"2018","unstructured":"Madeo, M. et al. Cancer exosomes induce tumor innervation. Nat. Commun. 9, 4284 (2018).","journal-title":"Nat. Commun."},{"key":"556_CR169","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI82658","volume":"126","author":"S Deborde","year":"2016","unstructured":"Deborde, S. et al. Schwann cells induce cancer cell dispersion and invasion. J. Clin. Investig. 126, 1538\u20131554 (2016).","journal-title":"J. Clin. Investig."},{"key":"556_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2116-x","volume":"10","author":"E Roger","year":"2019","unstructured":"Roger, E. et al. Schwann cells support oncogenic potential of pancreatic cancer cells through TGF\u03b2 signaling. Cell Death Dis. 10, 886 (2019).","journal-title":"Cell Death Dis."},{"key":"556_CR171","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3389\/fonc.2020.01601","volume":"10","author":"A Ferdoushi","year":"2020","unstructured":"Ferdoushi, A. et al. Schwann cell stimulation of pancreatic cancer cells: a proteomic analysis. Front. Oncol. 10, 1601 (2020).","journal-title":"Front. Oncol."},{"key":"556_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30466-6","volume":"13","author":"C Anastasaki","year":"2022","unstructured":"Anastasaki, C. et al. Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. Nat. Commun. 13, 2785 (2022).","journal-title":"Nat. Commun."},{"key":"556_CR173","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/glia.23969","volume":"69","author":"J Patritti-Cram","year":"2021","unstructured":"Patritti-Cram, J., Coover, R. A., Jankowski, M. P. & Ratner, N. Purinergic signaling in peripheral nervous system glial cells. Glia 69, 1837\u20131851 (2021).","journal-title":"Glia"},{"key":"556_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2413","volume":"4","author":"GN Armaiz-Pena","year":"2013","unstructured":"Armaiz-Pena, G. N. et al. Src activation by \u03b2-adrenoreceptors is a key switch for tumour metastasis. Nat. Commun. 4, 1403 (2013).","journal-title":"Nat. Commun."},{"key":"556_CR175","first-page":"584","volume":"59","author":"X Lin","year":"2012","unstructured":"Lin, X., Luo, K., Lv, Z. & Huang, J. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice. Hepatogastroenterology 59, 584\u2013588 (2012).","journal-title":"Hepatogastroenterology"},{"key":"556_CR176","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1096\/fj.15-277798","volume":"30","author":"CK Pon","year":"2016","unstructured":"Pon, C. K., Lane, J. R., Sloan, E. K. & Halls, M. L. The \u03b22-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion. FASEB J. 30, 1144\u20131154 (2016).","journal-title":"FASEB J."},{"key":"556_CR177","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature10368","volume":"477","author":"MR Hara","year":"2011","unstructured":"Hara, M. R. et al. A stress response pathway regulates DNA damage through \u03b22-adrenoreceptors and \u03b2-arrestin-1. Nature 477, 349\u2013353 (2011).","journal-title":"Nature"},{"key":"556_CR178","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.psyneuen.2014.11.008","volume":"52","author":"J Liu","year":"2015","unstructured":"Liu, J. et al. The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models. Psychoneuroendocrinology 52, 130\u2013142 (2015).","journal-title":"Psychoneuroendocrinology"},{"key":"556_CR179","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1756-9966-33-21","volume":"33","author":"GH Deng","year":"2014","unstructured":"Deng, G. H. et al. Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model. J. Exp. Clin. Cancer Res. 33, 21 (2014).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"556_CR180","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/MPA.0b013e318184f50c","volume":"38","author":"D Zhang","year":"2009","unstructured":"Zhang, D., Ma, Q., Shen, S. & Hu, H. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction. The study of \u03b2-adrenoceptor antagonist\u2019s anticancer effect in pancreatic cancer cell. Pancreas 38, 94\u2013100 (2009).","journal-title":"Pancreas"},{"key":"556_CR181","doi-asserted-by":"publisher","first-page":"68314","DOI":"10.18632\/oncotarget.11599","volume":"7","author":"C Zhou","year":"2016","unstructured":"Zhou, C. et al. Propranolol induced G0\/G1\/S phase arrest and apoptosis in melanoma cells via AKT\/MAPK pathway. Oncotarget 7, 68314\u201368327 (2016).","journal-title":"Oncotarget"},{"key":"556_CR182","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.18632\/oncotarget.2887","volume":"6","author":"GN Armaiz-Pena","year":"2015","unstructured":"Armaiz-Pena, G. N. et al. Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth. Oncotarget 6, 4266\u20134273 (2015).","journal-title":"Oncotarget"},{"key":"556_CR183","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour, H. et al. \u03b22 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J. Clin. Investig. 129, 5537\u20135552 (2019).","journal-title":"J. Clin. Investig."},{"key":"556_CR184","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","volume":"77","author":"MJ Bucsek","year":"2017","unstructured":"Bucsek, M. J. et al. \u03b2-Adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8+ T cells and undermines checkpoint inhibitor therapy. Cancer Res. 77, 5639\u20135651 (2017).","journal-title":"Cancer Res."},{"key":"556_CR185","doi-asserted-by":"publisher","first-page":"77825","DOI":"10.18632\/oncotarget.12833","volume":"7","author":"L Jean Wrobel","year":"2016","unstructured":"Jean Wrobel, L. et al. Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma. Oncotarget 7, 77825\u201377837 (2016).","journal-title":"Oncotarget"},{"key":"556_CR186","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.aah5072","volume":"358","author":"AH Zahalka","year":"2017","unstructured":"Zahalka, A. H. et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science 358, 321\u2013326 (2017).","journal-title":"Science"},{"key":"556_CR187","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-08-4289","volume":"69","author":"D Chakroborty","year":"2009","unstructured":"Chakroborty, D., Sarkar, C., Basu, B., Dasgupta, P. S. & Basu, S. Catecholamines regulate tumor angiogenesis. Cancer Res. 69, 3727\u20133730 (2009).","journal-title":"Cancer Res."},{"key":"556_CR188","doi-asserted-by":"publisher","first-page":"10357","DOI":"10.1158\/0008-5472.CAN-06-2496","volume":"66","author":"EV Yang","year":"2006","unstructured":"Yang, E. V. et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 66, 10357\u201310364 (2006).","journal-title":"Cancer Res."},{"key":"556_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10634","volume":"7","author":"CP Le","year":"2016","unstructured":"Le, C. P. et al. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat. Commun. 7, 10634 (2016).","journal-title":"Nat. Commun."},{"key":"556_CR190","doi-asserted-by":"publisher","first-page":"797","DOI":"10.18632\/oncotarget.343","volume":"2","author":"E Pasquier","year":"2011","unstructured":"Pasquier, E. et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget 2, 797\u2013809 (2011).","journal-title":"Oncotarget"},{"key":"556_CR191","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neuroscience.2007.07.048","volume":"149","author":"B Raju","year":"2007","unstructured":"Raju, B., Haug, S. R., Ibrahim, S. O. & Heyeraas, K. J. Sympathectomy decreases size and invasiveness of tongue cancer in rats. Neuroscience 149, 715\u2013725 (2007).","journal-title":"Neuroscience"},{"key":"556_CR192","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93076","author":"AS Nagaraja","year":"2017","unstructured":"Nagaraja, A. S. et al. Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.93076 (2017).","journal-title":"JCI Insight"},{"key":"556_CR193","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.18632\/oncotarget.2652","volume":"6","author":"M Calvani","year":"2015","unstructured":"Calvani, M. et al. Norepinephrine promotes tumor microenvironment reactivity through beta3-adrenoreceptors during melanoma progression. Oncotarget 6, 4615\u20134632 (2015).","journal-title":"Oncotarget"},{"key":"556_CR194","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.tranon.2017.12.009","volume":"11","author":"J Gyamfi","year":"2018","unstructured":"Gyamfi, J., Eom, M., Koo, J. S. & Choi, J. Multifaceted roles of interleukin-6 in adipocyte-breast cancer cell interaction. Transl. Oncol. 11, 275\u2013285 (2018).","journal-title":"Transl. Oncol."},{"key":"556_CR195","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","volume":"20","author":"M Petruzzelli","year":"2014","unstructured":"Petruzzelli, M. et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 20, 433\u2013447 (2014).","journal-title":"Cell Metab."},{"key":"556_CR196","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.05.029","volume":"142","author":"L Cao","year":"2010","unstructured":"Cao, L. et al. Environmental and genetic activation of a brain-adipocyte BDNF\/leptin axis causes cancer remission and inhibition. Cell 142, 52\u201364 (2010).","journal-title":"Cell"},{"key":"556_CR197","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/cas.12438","volume":"105","author":"T Shan","year":"2014","unstructured":"Shan, T. et al. Novel regulatory program for norepinephrine-induced epithelial-mesenchymal transition in gastric adenocarcinoma cell lines. Cancer Sci. 105, 847\u2013856 (2014).","journal-title":"Cancer Sci."},{"key":"556_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-015-2477-0","volume":"408","author":"YJ Lu","year":"2015","unstructured":"Lu, Y. J. et al. Isoprenaline induces epithelial-mesenchymal transition in gastric cancer cells. Mol. Cell. Biochem. 408, 1\u201313 (2015).","journal-title":"Mol. Cell. Biochem."},{"key":"556_CR199","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.bbrc.2017.09.146","volume":"493","author":"J Pu","year":"2017","unstructured":"Pu, J. et al. Adrenaline promotes epithelial-to-mesenchymal transition via HuR-TGF\u03b2 regulatory axis in pancreatic cancer cells and the implication in cancer prognosis. Biochem. Biophys. Res. Commun. 493, 1273\u20131279 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"556_CR200","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00432-015-2044-9","volume":"142","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro. J. Cancer Res. Clin. Oncol. 142, 423\u2013435 (2016).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"556_CR201","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-11-0249","volume":"20","author":"S Lemeshow","year":"2011","unstructured":"Lemeshow, S. et al. \u03b2-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol. Biomark. Prev. 20, 2273\u20132279 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"556_CR202","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archinternmed.2011.131","volume":"171","author":"V De Giorgi","year":"2011","unstructured":"De Giorgi, V. et al. Treatment with \u03b2-blockers and reduced disease progression in patients with thick melanoma. Arch. Intern. Med. 171, 779\u2013781 (2011).","journal-title":"Arch. Intern. Med."},{"key":"556_CR203","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1405205","volume":"7","author":"KM Kokolus","year":"2018","unstructured":"Kokolus, K. M. et al. Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. Oncoimmunology 7, e1405205 (2018).","journal-title":"Oncoimmunology"},{"key":"556_CR204","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1158\/0008-5472.CAN-17-0108","volume":"77","author":"R Udumyan","year":"2017","unstructured":"Udumyan, R. et al. Beta-blocker drug use and survival among patients with pancreatic adenocarcinoma. Cancer Res. 77, 3700\u20133707 (2017).","journal-title":"Cancer Res."},{"key":"556_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.01.007","author":"HH Grytli","year":"2013","unstructured":"Grytli, H. H., Fagerland, M. W., Fossa, S. D. & Tasken, K. A. Association between use of \u03b2-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur. Urol. https:\/\/doi.org\/10.1016\/j.eururo.2013.01.007 (2013).","journal-title":"Eur. Urol."},{"key":"556_CR206","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/pros.22564","volume":"73","author":"HH Grytli","year":"2013","unstructured":"Grytli, H. H., Fagerland, M. W., Fossa, S. D., Tasken, K. A. & Haheim, L. L. Use of \u03b2-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy. Prostate 73, 250\u2013260 (2013).","journal-title":"Prostate"},{"key":"556_CR207","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","volume":"29","author":"A Melhem-Bertrandt","year":"2011","unstructured":"Melhem-Bertrandt, A. et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J. Clin. Oncol. 29, 2645\u20132652 (2011).","journal-title":"J. Clin. Oncol."},{"key":"556_CR208","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","volume":"29","author":"TI Barron","year":"2011","unstructured":"Barron, T. I., Connolly, R. M., Sharp, L., Bennett, K. & Visvanathan, K. Beta blockers and breast cancer mortality: a population- based study. J. Clin. Oncol. 29, 2635\u20132644 (2011).","journal-title":"J. Clin. Oncol."},{"key":"556_CR209","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10549-013-2654-3","volume":"140","author":"E Botteri","year":"2013","unstructured":"Botteri, E. et al. Therapeutic effect of beta-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Res. Treat. 140, 567\u2013575 (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"556_CR210","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrclinonc.2011.123","volume":"8","author":"DG Powe","year":"2011","unstructured":"Powe, D. G. & Entschladen, F. Targeted therapies: using \u03b2-blockers to inhibit breast cancer progression. Nat. Rev. Clin. Oncol. 8, 511\u2013512 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"556_CR211","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ygyno.2012.07.102","volume":"127","author":"ES Diaz","year":"2012","unstructured":"Diaz, E. S., Karlan, B. Y. & Li, A. J. Impact of beta blockers on epithelial ovarian cancer survival. Gynecol. Oncol. 127, 375\u2013378 (2012).","journal-title":"Gynecol. Oncol."},{"key":"556_CR212","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/cncr.28546","volume":"120","author":"L Jansen","year":"2014","unstructured":"Jansen, L., Hoffmeister, M., Arndt, V., Chang-Claude, J. & Brenner, H. Stage-specific associations between beta blocker use and prognosis after colorectal cancer. Cancer 120, 1178\u20131186 (2014).","journal-title":"Cancer"},{"key":"556_CR213","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/annonc\/mds616","volume":"24","author":"HM Wang","year":"2013","unstructured":"Wang, H. M. et al. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann. Oncol. 24, 1312\u20131319 (2013).","journal-title":"Ann. Oncol."},{"key":"556_CR214","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/S1470-2045(21)00596-9","volume":"23","author":"DD Shi","year":"2022","unstructured":"Shi, D. D. et al. Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities. Lancet Oncol. 23, e62\u2013e74 (2022).","journal-title":"Lancet Oncol."},{"key":"556_CR215","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","volume":"26","author":"JG Hiller","year":"2020","unstructured":"Hiller, J. G. et al. Preoperative \u03b2-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial. Clin. Cancer Res. 26, 1803\u20131811 (2020).","journal-title":"Clin. Cancer Res."},{"key":"556_CR216","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-17-0152","volume":"23","author":"L Shaashua","year":"2017","unstructured":"Shaashua, L. et al. Perioperative COX-2 and \u03b2-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial. Clin. Cancer Res. 23, 4651\u20134661 (2017).","journal-title":"Clin. Cancer Res."},{"key":"556_CR217","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2908","volume":"4","author":"V De Giorgi","year":"2018","unstructured":"De Giorgi, V. et al. Propranolol for off-label treatment of patients with melanoma: results from a cohort study. JAMA Oncol. 4, e172908 (2018).","journal-title":"JAMA Oncol."},{"key":"556_CR218","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1182\/bloodadvances.2019000765","volume":"4","author":"JM Knight","year":"2020","unstructured":"Knight, J. M. et al. Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. Blood Adv. 4, 467\u2013476 (2020).","journal-title":"Blood Adv."},{"key":"556_CR219","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/2159-8290.CD-18-0046","volume":"8","author":"BW Renz","year":"2018","unstructured":"Renz, B. W. et al. Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness. Cancer Discov. 8, 1458\u20131473 (2018).","journal-title":"Cancer Discov."},{"key":"556_CR220","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1200\/JCO.2011.37.0189","volume":"30","author":"V Koppelmans","year":"2012","unstructured":"Koppelmans, V. et al. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J. Clin. Oncol. 30, 1080\u20131086 (2012).","journal-title":"J. Clin. Oncol."},{"key":"556_CR221","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nm1029","volume":"10","author":"Y Qi","year":"2004","unstructured":"Qi, Y. et al. Adiponectin acts in the brain to decrease body weight. Nat. Med. 10, 524\u2013529 (2004).","journal-title":"Nat. Med."},{"key":"556_CR222","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35051587","volume":"409","author":"M Nakazato","year":"2001","unstructured":"Nakazato, M. et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194\u2013198 (2001).","journal-title":"Nature"},{"key":"556_CR223","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cmet.2008.12.001","volume":"9","author":"MG Myers Jr.","year":"2009","unstructured":"Myers, M. G. Jr., Munzberg, H., Leinninger, G. M. & Leshan, R. L. The geometry of leptin action in the brain: more complicated than a simple ARC. Cell Metab. 9, 117\u2013123 (2009).","journal-title":"Cell Metab."},{"key":"556_CR224","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.tem.2010.08.002","volume":"21","author":"MG Myers Jr","year":"2010","unstructured":"Myers, M. G. Jr, Leibel, R. L., Seeley, R. J. & Schwartz, M. W. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol. Metab. 21, 643\u2013651 (2010).","journal-title":"Trends Endocrinol. Metab."},{"key":"556_CR225","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan, B. et al. Body fatness and cancer \u2014 viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794\u2013798 (2016).","journal-title":"N. Engl. J. Med."},{"key":"556_CR226","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-05-1913","volume":"12","author":"C Garofalo","year":"2006","unstructured":"Garofalo, C. et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin. Cancer Res. 12, 1447\u20131453 (2006).","journal-title":"Clin. Cancer Res."},{"key":"556_CR227","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel, A. E. et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell 183, 1848\u20131866 (2020).","journal-title":"Cell"},{"key":"556_CR228","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ncpendmet0456","volume":"3","author":"A Schaffler","year":"2007","unstructured":"Schaffler, A., Scholmerich, J. & Buechler, C. Mechanisms of disease: adipokines and breast cancer \u2014 endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat. Clin. Pract. Endocrinol. Metab. 3, 345\u2013354 (2007).","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"556_CR229","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498\u20131503 (2011).","journal-title":"Nat. Med."},{"key":"556_CR230","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-03-0749","volume":"10","author":"M Ishikawa","year":"2004","unstructured":"Ishikawa, M., Kitayama, J. & Nagawa, H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin. Cancer Res. 10, 4325\u20134331 (2004).","journal-title":"Clin. Cancer Res."},{"key":"556_CR231","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.cmet.2018.04.018","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab. 27, 1357 (2018).","journal-title":"Cell Metab."},{"key":"556_CR232","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cmet.2009.06.011","volume":"10","author":"GM Leinninger","year":"2009","unstructured":"Leinninger, G. M. et al. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab. 10, 89\u201398 (2009).","journal-title":"Cell Metab."},{"key":"556_CR233","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nrn.2016.24","volume":"17","author":"B Xu","year":"2016","unstructured":"Xu, B. & Xie, X. Neurotrophic factor control of satiety and body weight. Nat. Rev. Neurosci. 17, 282\u2013292 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"556_CR234","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41586-020-2527-y","volume":"583","author":"P Wang","year":"2020","unstructured":"Wang, P. et al. A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue. Nature 583, 839\u2013844 (2020).","journal-title":"Nature"},{"key":"556_CR235","first-page":"774","volume":"9","author":"Y Shimizu","year":"2003","unstructured":"Shimizu, Y. et al. Increased plasma ghrelin level in lung cancer cachexia. Clin. Cancer Res. 9, 774\u2013778 (2003).","journal-title":"Clin. Cancer Res."},{"key":"556_CR236","doi-asserted-by":"publisher","first-page":"48671","DOI":"10.18632\/oncotarget.8932","volume":"7","author":"T Wei","year":"2016","unstructured":"Wei, T., Ye, P., Peng, X., Wu, L. L. & Yu, G. Y. Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies. Oncotarget 7, 48671\u201348691 (2016).","journal-title":"Oncotarget"},{"key":"556_CR237","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023302","volume":"6","author":"MD Gahete","year":"2011","unstructured":"Gahete, M. D. et al. A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance. PLoS ONE 6, e23302 (2011).","journal-title":"PLoS ONE"},{"key":"556_CR238","first-page":"265","volume":"6","author":"CC Au","year":"2016","unstructured":"Au, C. C., Furness, J. B. & Brown, K. A. Ghrelin and breast cancer: emerging roles in obesity, estrogen regulation, and cancer. Front. Oncol. 6, 265 (2016).","journal-title":"Front. Oncol."},{"key":"556_CR239","first-page":"613","volume":"15","author":"JJ Olin","year":"2001","unstructured":"Olin, J. J. Cognitive function after systemic therapy for breast cancer. Oncology 15, 613\u2013618 (2001).","journal-title":"Oncology"},{"key":"556_CR240","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/annonc\/mdv206","volume":"26","author":"YT Cheung","year":"2015","unstructured":"Cheung, Y. T. et al. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann. Oncol. 26, 1446\u20131451 (2015).","journal-title":"Ann. Oncol."},{"key":"556_CR241","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208593","volume":"13","author":"AK Walker","year":"2018","unstructured":"Walker, A. K. et al. Low dose aspirin blocks breast cancer-induced cognitive impairment in mice. PLoS ONE 13, e0208593 (2018).","journal-title":"PLoS ONE"},{"key":"556_CR242","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1158\/0008-5472.CAN-16-0899","volume":"77","author":"S Sinha","year":"2017","unstructured":"Sinha, S. et al. PanIN neuroendocrine cells promote tumorigenesis via neuronal cross-talk. Cancer Res. 77, 1868\u20131879 (2017).","journal-title":"Cancer Res."},{"key":"556_CR243","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nrn1914","volume":"7","author":"PW Mantyh","year":"2006","unstructured":"Mantyh, P. W. Cancer pain and its impact on diagnosis, survival and quality of life. Nat. Rev. Neurosci. 7, 797\u2013809 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"556_CR244","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41586-022-04719-9","volume":"606","author":"P Chen","year":"2022","unstructured":"Chen, P. et al. Olfactory sensory experience regulates gliomagenesis via neuronal IGF1. Nature 606, 550\u2013556 (2022).","journal-title":"Nature"},{"key":"556_CR245","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/1073858414525828","volume":"20","author":"BL Schmidt","year":"2014","unstructured":"Schmidt, B. L. The neurobiology of cancer pain. Neuroscientist 20, 546\u2013562 (2014).","journal-title":"Neuroscientist"},{"key":"556_CR246","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1097\/j.pain.0000000000000099","volume":"156","author":"BL Schmidt","year":"2015","unstructured":"Schmidt, B. L. What pain tells us about cancer. Pain 156, S32\u2013S34 (2015).","journal-title":"Pain"},{"key":"556_CR247","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031902","author":"A Bortolin","year":"2022","unstructured":"Bortolin, A., Neto, E. & Lamghari, M. Calcium signalling in breast cancer associated bone pain. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23031902 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"556_CR248","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nn.4574","volume":"20","author":"CA Campos","year":"2017","unstructured":"Campos, C. A. et al. Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus. Nat. Neurosci. 20, 934\u2013942 (2017).","journal-title":"Nat. Neurosci."},{"key":"556_CR249","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tins.2018.03.007","volume":"41","author":"RD Palmiter","year":"2018","unstructured":"Palmiter, R. D. The parabrachial nucleus: CGRP neurons function as a general alarm. Trends Neurosci. 41, 280\u2013293 (2018).","journal-title":"Trends Neurosci."},{"key":"556_CR250","doi-asserted-by":"publisher","first-page":"14649","DOI":"10.1523\/JNEUROSCI.3300-10.2010","volume":"30","author":"JM Jimenez-Andrade","year":"2010","unstructured":"Jimenez-Andrade, J. M. et al. Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J. Neurosci. 30, 14649\u201314656 (2010).","journal-title":"J. Neurosci."},{"key":"556_CR251","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","volume":"611","author":"M Balood","year":"2022","unstructured":"Balood, M. et al. Nociceptor neurons affect cancer immunosurveillance. Nature 611, 405\u2013412 (2022).","journal-title":"Nature"},{"key":"556_CR252","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00006842-198005000-00005","volume":"42","author":"LS Sklar","year":"1980","unstructured":"Sklar, L. S. & Anisman, H. Social stress influences tumor growth. Psychosom. Med. 42, 347\u2013365 (1980).","journal-title":"Psychosom. Med."},{"key":"556_CR253","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0889-1591(03)00078-3","volume":"17","author":"S Sephton","year":"2003","unstructured":"Sephton, S. & Spiegel, D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease. Brain Behav. Immun. 17, 321\u2013328 (2003).","journal-title":"Brain Behav. Immun."},{"key":"556_CR254","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jneuroim.2003.11.011","volume":"148","author":"H Engler","year":"2004","unstructured":"Engler, H., Bailey, M. T., Engler, A. & Sheridan, J. F. Effects of repeated social stress on leukocyte distribution in bone marrow, peripheral blood and spleen. J. Neuroimmunol. 148, 106\u2013115 (2004).","journal-title":"J. Neuroimmunol."},{"key":"556_CR255","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jneuroim.2004.08.005","volume":"156","author":"H Engler","year":"2004","unstructured":"Engler, H. et al. Effects of social stress on blood leukocyte distribution: the role of \u03b1- and \u03b2-adrenergic mechanisms. J. Neuroimmunol. 156, 153\u2013162 (2004).","journal-title":"J. Neuroimmunol."},{"key":"556_CR256","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fonc.2019.01014","volume":"9","author":"S Soleyman-Jahi","year":"2019","unstructured":"Soleyman-Jahi, S. et al. Attribution of ghrelin to cancer; attempts to unravel an apparent controversy. Front. Oncol. 9, 1014 (2019).","journal-title":"Front. Oncol."},{"key":"556_CR257","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal5081","author":"C Engblom","year":"2017","unstructured":"Engblom, C. et al. Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF(high) neutrophils. Science https:\/\/doi.org\/10.1126\/science.aal5081 (2017).","journal-title":"Science"},{"key":"556_CR258","doi-asserted-by":"publisher","first-page":"9387","DOI":"10.18632\/oncotarget.3328","volume":"6","author":"JR Lakritz","year":"2015","unstructured":"Lakritz, J. R. et al. Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget 6, 9387\u20139396 (2015).","journal-title":"Oncotarget"},{"key":"556_CR259","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","volume":"156","author":"F De Vadder","year":"2014","unstructured":"De Vadder, F. et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84\u201396 (2014).","journal-title":"Cell"},{"key":"556_CR260","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat5236","author":"MM Kaelberer","year":"2018","unstructured":"Kaelberer, M. M. et al. A gut-brain neural circuit for nutrient sensory transduction. Science https:\/\/doi.org\/10.1126\/science.aat5236 (2018).","journal-title":"Science"},{"key":"556_CR261","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cell.2016.05.011","volume":"166","author":"EK Williams","year":"2016","unstructured":"Williams, E. K. et al. Sensory neurons that detect stretch and nutrients in the digestive system. Cell 166, 209\u2013221 (2016).","journal-title":"Cell"},{"key":"556_CR262","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-020-2235-7","volume":"581","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Brain control of humoral immune responses amenable to behavioural modulation. Nature 581, 204\u2013208 (2020).","journal-title":"Nature"},{"key":"556_CR263","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.yfrne.2017.10.005","volume":"48","author":"AD de Kloet","year":"2018","unstructured":"de Kloet, A. D. & Herman, J. P. Fat-brain connections: adipocyte glucocorticoid control of stress and metabolism. Front. Neuroendocrinol. 48, 50\u201357 (2018).","journal-title":"Front. Neuroendocrinol."},{"key":"556_CR264","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202106078","author":"A Abu Rmaileh","year":"2022","unstructured":"Abu Rmaileh, A. et al. DPYSL2 interacts with JAK1 to mediate breast cancer cell migration. J. Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202106078 (2022).","journal-title":"J. Cell Biol."},{"key":"556_CR265","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541\u2013550 (2018).","journal-title":"Nat. Med."},{"key":"556_CR266","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nri3902","volume":"15","author":"SJ Turley","year":"2015","unstructured":"Turley, S. J., Cremasco, V. & Astarita, J. L. Immunological hallmarks of stromal cells in the tumour microenvironment. Nat. Rev. Immunol. 15, 669\u2013682 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"556_CR267","doi-asserted-by":"publisher","first-page":"13203","DOI":"10.1073\/pnas.0806582105","volume":"105","author":"Y Cao","year":"2008","unstructured":"Cao, Y. & Langer, R. A review of Judah Folkman\u2019s remarkable achievements in biomedicine. Proc. Natl Acad. Sci. USA 105, 13203\u201313205 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"556_CR268","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"J Folkman","year":"2007","unstructured":"Folkman, J. Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discov. 6, 273\u2013286 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"556_CR269","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","volume":"15","author":"M Paez-Ribes","year":"2009","unstructured":"Paez-Ribes, M. et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220\u2013231 (2009).","journal-title":"Cancer Cell"},{"key":"556_CR270","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","volume":"15","author":"JM Ebos","year":"2009","unstructured":"Ebos, J. M. et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15, 232\u2013239 (2009).","journal-title":"Cancer Cell"},{"key":"556_CR271","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ccr.2011.11.023","volume":"21","author":"AA Van der Veldt","year":"2012","unstructured":"Van der Veldt, A. A. et al. Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs. Cancer Cell 21, 82\u201391 (2012).","journal-title":"Cancer Cell"},{"key":"556_CR272","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld, A. J. & Hellmann, M. D. Acquired resistance to immune checkpoint inhibitors. Cancer Cell 37, 443\u2013455 (2020).","journal-title":"Cancer Cell"},{"key":"556_CR273","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1002\/cncr.33074","volume":"126","author":"K Van der Gucht","year":"2020","unstructured":"Van der Gucht, K. et al. Effects of a mindfulness-based intervention on cancer-related cognitive impairment: results of a randomized controlled functional magnetic resonance imaging pilot study. Cancer 126, 4246\u20134255 (2020).","journal-title":"Cancer"},{"key":"556_CR274","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/cncr.29194","volume":"121","author":"JE Bower","year":"2015","unstructured":"Bower, J. E. et al. Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial. Cancer 121, 1231\u20131240 (2015).","journal-title":"Cancer"},{"key":"556_CR275","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.ejca.2012.10.030","volume":"49","author":"H Wurtzen","year":"2013","unstructured":"Wurtzen, H. et al. Mindfulness significantly reduces self-reported levels of anxiety and depression: results of a randomised controlled trial among 336 Danish women treated for stage I-III breast cancer. Eur. J. Cancer 49, 1365\u20131373 (2013).","journal-title":"Eur. J. Cancer"},{"key":"556_CR276","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nrc1820","volume":"6","author":"MH Antoni","year":"2006","unstructured":"Antoni, M. H. et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 6, 240\u2013248 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"556_CR277","doi-asserted-by":"publisher","first-page":"pky029","DOI":"10.1093\/jncics\/pky029","volume":"2","author":"JE Bower","year":"2018","unstructured":"Bower, J. E. et al. Prometastatic molecular profiles in breast tumors from socially isolated women. JNCI Cancer Spectr. 2, pky029 (2018).","journal-title":"JNCI Cancer Spectr."},{"key":"556_CR278","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/pon.4838","volume":"27","author":"SW Cole","year":"2018","unstructured":"Cole, S. W. New challenges in psycho-oncology: neural regulation of the cancer genome. Psychooncology 27, 2305\u20132309 (2018).","journal-title":"Psychooncology"},{"key":"556_CR279","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02944201 (2019)."},{"key":"556_CR280","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03861598 (2019)."},{"key":"556_CR281","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03384836 (2017)."},{"key":"556_CR282","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03838029 (2019)."},{"key":"556_CR283","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03919461 (2019)."},{"key":"556_CR284","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","volume":"15","author":"JG Hiller","year":"2020","unstructured":"Hiller, J. G. et al. Preoperative \u03b2-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial. Clin. Cancer Res. 15, 1803\u20131811 (2020).","journal-title":"Clin. Cancer Res."},{"key":"556_CR285","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03122444 (2017)."},{"key":"556_CR286","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00667121 (2008)."},{"key":"556_CR287","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03919292 (2019)."},{"key":"556_CR288","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04310176 (2020)."},{"key":"556_CR289","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01530373 (2012)."},{"key":"556_CR290","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02609828 (2015)."},{"key":"556_CR291","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41388-022-02290-1","volume":"41","author":"BN Somatilaka","year":"2022","unstructured":"Somatilaka, B. N., Sadek, A., McKay, R. M. & Le, L. Q. Malignant peripheral nerve sheath tumor: models, biology, and translation. Oncogene 41, 2405\u20132421 (2022).","journal-title":"Oncogene"},{"key":"556_CR292","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73511","author":"J Patritti Cram","year":"2022","unstructured":"Patritti Cram, J. et al. P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis. eLife https:\/\/doi.org\/10.7554\/eLife.73511 (2022).","journal-title":"eLife"},{"key":"556_CR293","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.acr.2022.04.001","volume":"155","author":"V Rao","year":"2022","unstructured":"Rao, V. et al. Chemobrain: a review on mechanistic insight, targets and treatments. Adv. Cancer Res. 155, 29\u201376 (2022).","journal-title":"Adv. Cancer Res."},{"key":"556_CR294","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/CCO.0000000000000578","volume":"31","author":"EM Gibson","year":"2019","unstructured":"Gibson, E. M. & Monje, M. Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment. Curr. Opin. Oncol. 31, 531\u2013539 (2019).","journal-title":"Curr. Opin. Oncol."},{"key":"556_CR295","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuron.2019.04.032","volume":"103","author":"AC Geraghty","year":"2019","unstructured":"Geraghty, A. C. et al. Loss of adaptive myelination contributes to methotrexate chemotherapy-related cognitive impairment. Neuron 103, 250\u2013265 (2019).","journal-title":"Neuron"},{"key":"556_CR296","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cell.2018.10.049","volume":"176","author":"EM Gibson","year":"2019","unstructured":"Gibson, E. M. et al. Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment. Cell 176, 43\u201355 (2019).","journal-title":"Cell"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-023-00556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-023-00556-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-023-00556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T07:09:30Z","timestamp":1684307370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-023-00556-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":296,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1038\/s41568-023-00556-8","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"23 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}